Literature DB >> 2018550

Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Oxidation of valproate by liver peroxisomes.

S Ponchaut1, J P Draye, K Veitch, F Van Hoof.   

Abstract

Chronic administration to rats of the anticonvulsant drug, valproate, induced proliferation of liver peroxisomes and selectively increased the activity of the enzymes involved in beta-oxidation in these organelles. In kidney cortex, only a moderate increase in enzyme activity could be recorded. Valproate (1% w/w in the diet for 25 to 100 days) caused the appearance on electron micrographs of unusual tubular inclusions in the matrix of liver peroxisomes. SDS-PAGE analysis of purified peroxisomal fractions from treated rats demonstrated an increase in the content of five polypeptides; four of which most likely correspond to enzymes of the peroxisomal beta-oxidation. It is suggested that the peroxisomal inclusions correspond to the accumulation of these polypeptides in the matrix of the organelle. An in vivo evaluation of the peroxisomal hydrogen peroxide production suggested that valproate itself or one of its metabolites is substrate for peroxisomal beta-oxidation. This was confirmed by in vitro studies. Activation of valproate or its metabolites by liver acyl-CoA synthetase could be demonstrated, although it was 50 times slower than that of octanoate. This reaction further led to a small, but significant production of H2O2 by the action of peroxisomal acyl-CoA oxidase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018550     DOI: 10.1016/0006-2952(91)90557-l

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.

Authors:  Jitendriya Mishra; Tanya Chaudhary; Anil Kumar
Journal:  Neurotox Res       Date:  2014-02-25       Impact factor: 3.911

2.  Apparent autoinduction of valproate beta-oxidation in humans.

Authors:  D B McLaughlin; J A Andrews; W D Hooper; G R Cannell; M J Eadie; R G Dickinson
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

3.  Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate.

Authors:  Martin J Lan; Peixiong Yuan; Guang Chen; Husseini K Manji
Journal:  J Mol Neurosci       Date:  2008-04-25       Impact factor: 3.444

Review 4.  Modes of action of trichloroethylene for kidney tumorigenesis.

Authors:  L H Lash; J C Parker; C S Scott
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

5.  Effects of naringin and valproate interaction on liver steatosis and dyslipidaemia parameters in male C57BL6 mice.

Authors:  David Jutrić; Domagoj Đikić; Almoš Boroš; Dyna Odeh; Sandra Domjanić Drozdek; Romana Gračan; Petar Dragičević; Irena Crnić; Irena Landeka Jurčević
Journal:  Arh Hig Rada Toksikol       Date:  2022-04-07       Impact factor: 2.078

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.